Skip to main content
Livermore
Livermore
ZHEN

Perceptive Advisors LLC

SEC CIK
0001224962
Latest filing
Aug 14, 2026

Holdings in Q3 2022

Holdings as of Sep 30, 2022, filed Nov 14, 2022. Long positions only; changes compare share counts with Q2 2022.

Institution overview
Positions
115
+6 vs. Q2 2022
Portfolio value
$3.44B
+$257.8M (+8.1%) vs. Q2 2022
Filed
Nov 14, 2022
SEC
Holdings of Perceptive Advisors LLC in Q3 2022
SecurityClassSharesValue% of portfolioShare changeActionHistory
SRZNSurrozen, Inc.COM6,017$12.0K<0.1%00.0%UnchangedHistory
Surrozen, Inc.86889P117*W EXP 08/01/203166,666$31.0K<0.1%00.0%Unchanged–
NEPTFNeptune Wellness Solutions Inc.COM NEW57,142$87.0K<0.1%00.0%UnchangedHistory
CareMax, Inc.14171W111*W EXP 06/08/20260,000$113.0K<0.1%00.0%Unchanged–
AGRXAgile Therapeutics IncCOM NEW532,361$158.0K<0.1%00.0%UnchangedHistory
EQRx, Inc.26886C115*W EXP 12/17/202250,000$205.0K<0.1%00.0%Unchanged–
MOTSMotus GI Holdings, Inc.COM NEW90,027$221.0K<0.1%00.0%UnchangedConverted for a 1-for-20 splitHistory
ICVXIcosavax, Inc.COM93,591$296.0K<0.1%−949,259−91.0%ReducedHistory
PRVBProvention Bio, Inc.COM110,728$498.0K<0.1%00.0%UnchangedHistory
SONXSonendo, Inc.COM612,204$655.0K<0.1%−36,301−5.6%ReducedHistory
HYPRHyperfine, Inc.COM CL A927,388$751.0K<0.1%−207,000−18.2%ReducedHistory
TARAProtara Therapeutics, Inc.COM STK290,051$859.0K<0.1%00.0%UnchangedHistory
DRIODarioHealth Corp.COM NEW327,869$1.52M<0.1%00.0%UnchangedHistory
PEARPear Therapeutics, Inc.CLASS A COM900,548$1.84M0.1%00.0%UnchangedHistory
TVTXTravere Therapeutics, Inc.COM90,748$2.24M0.1%−479,336−84.1%ReducedHistory
FULCFulcrum Therapeutics, Inc.COM294,118$2.38M0.1%00.0%UnchangedHistory
SNCEScience 37 Holdings, Inc.COM1,500,000$2.42M0.1%00.0%UnchangedHistory
QTNTQuotient LtdSHS16,200,818$2.43M0.1%00.0%UnchangedHistory
RETAReata Pharmaceuticals IncCL A100,000$2.51M0.1%+100,000NewHistory
CLOVClover Health Investments, Corp.COM CL A1,500,000$2.55M0.1%00.0%UnchangedHistory
PSTXPoseida Therapeutics, Inc.COM750,000$2.65M0.1%+750,000NewHistory
ABSIAbsci CorpCOM894,346$2.80M0.1%00.0%UnchangedHistory
PYXSPyxis Oncology, Inc.COMMON STOCK1,528,812$3.01M0.1%00.0%UnchangedHistory
YMABY-mAbs Therapeutics, Inc.COM212,018$3.06M0.1%00.0%UnchangedHistory
Coherus Biosciences Inc19249HAB9NOTE 1.500% 4/1–$3.59M0.1%–––
NBTXNanobiotix S.A.SPONSORED ADS1,059,800$3.75M0.1%00.0%UnchangedHistory
HCATHealth Catalyst, Inc.COM389,962$3.78M0.1%−75,200−16.2%ReducedHistory
PNTPOINT Biopharma Global Inc.COM500,000$3.87M0.1%−573,995−53.4%ReducedHistory
ABOSAcumen Pharmaceuticals, Inc.COM400,000$4.01M0.1%−108,532−21.3%ReducedHistory
ATNXAthenex, Inc.COM15,532,467$4.18M0.1%+2,000,000+14.8%AddedHistory
CTICCti Biopharma CorpCOM735,165$4.28M0.1%+735,165NewHistory
TYRATyra Biosciences, Inc.COM494,403$4.35M0.1%00.0%UnchangedHistory
SLGCSomaLogic, Inc.CLASS A COM1,500,000$4.35M0.1%00.0%UnchangedHistory
WGSGeneDx Holdings Corp.COMMON STOCK5,000,000$4.39M0.1%00.0%UnchangedHistory
NVNOenVVeno Medical CorpCOMMON STOCK781,615$4.91M0.1%00.0%UnchangedHistory
NARIInari Medical, Inc.Stock70,000$5.08M0.1%+70,000NewHistory
NTRANatera, Inc.COM120,000$5.26M0.2%+120,000NewHistory
ACRSAclaris Therapeutics, Inc.COM341,239$5.37M0.2%00.0%UnchangedHistory
RVMDRevolution Medicines, Inc.COM310,500$6.12M0.2%+310,500NewHistory
SLDBSolid Biosciences Inc.COM13,412,552$6.26M0.2%00.0%UnchangedHistory
CYPHCypherpunk Technologies Inc.COM7,472,148$6.58M0.2%−479,300−6.0%ReducedHistory
CCCCC4 Therapeutics, Inc.COM STK766,231$6.72M0.2%00.0%UnchangedHistory
NVRONevro CorpCOM150,000$6.99M0.2%+150,000NewHistory
ISOIsoPlexis CorpCOM4,095,498$7.04M0.2%00.0%UnchangedHistory
KRONKronos Bio, Inc.COM2,156,151$7.22M0.2%−264,991−10.9%ReducedHistory
RCKTRocket Pharmaceuticals, Inc.COM500,000$7.98M0.2%−666,883−57.2%ReducedHistory
OMICSingular Genomics Systems, Inc.COM3,536,274$8.84M0.3%00.0%UnchangedHistory
LRMRLarimar Therapeutics, Inc.COM2,860,000$9.15M0.3%+2,860,000NewHistory
LABPLandos Biopharma, Inc.COM14,869,915$9.66M0.3%00.0%UnchangedHistory
ChemoCentryx, Inc.16383L106COM192,680$9.95M0.3%−249,000−56.4%Reduced–
MORFMorphic Holding, Inc.COM363,197$10.3M0.3%00.0%UnchangedHistory
NBIXNeurocrine Biosciences IncStock100,050$10.6M0.3%−297,838−74.9%ReducedHistory
PRCTPROCEPT BioRobotics CorpCOM263,720$10.9M0.3%−485,980−64.8%ReducedHistory
AXGNAxogen, Inc.COM949,626$11.3M0.3%+949,626NewHistory
ATXSAstria Therapeutics, Inc.COM1,281,197$11.6M0.3%00.0%UnchangedHistory
Rain Oncology Inc.75082Q105COM2,483,619$12.1M0.4%00.0%Unchanged–
HLVXHilleVax, Inc.COM764,907$13.1M0.4%00.0%UnchangedHistory
DICEDICE Therapeutics, Inc.COM687,424$13.9M0.4%−364,480−34.6%ReducedHistory
PRTAProthena Corp Public Ltd CoSHS230,000$13.9M0.4%+230,000NewHistory
LONALeonaBio, Inc.COM4,797,278$14.2M0.4%00.0%UnchangedHistory
CNCEConcert Pharmaceuticals, Inc.COM2,150,641$14.4M0.4%00.0%UnchangedHistory
AKROAkero Therapeutics, Inc.COM430,000$14.6M0.4%+430,000NewHistory
VRCAVerrica Pharmaceuticals Inc.COM5,038,983$14.7M0.4%00.0%UnchangedHistory
CHRSCoherus Oncology, Inc.COM1,667,123$16.0M0.5%−1,978,348−54.3%ReducedHistory
AORTArtivion, Inc.COM1,204,229$16.7M0.5%+274,524+29.5%AddedHistory
BBIOBridgeBio Pharma, Inc.COM1,697,033$16.9M0.5%00.0%UnchangedHistory
RCUSArcus Biosciences, Inc.COM666,477$17.4M0.5%+666,477NewHistory
HRMYHarmony Biosciences Holdings, Inc.COM411,804$18.2M0.5%00.0%UnchangedHistory
ISEEIVERIC bio, Inc.COM1,034,169$18.6M0.5%−1,053,787−50.5%ReducedHistory
OMOutset Medical, Inc.COM1,168,630$18.6M0.5%+169,903+17.0%AddedHistory
CTKBCytek Biosciences, Inc.COM1,289,534$19.0M0.6%+1,289,534NewHistory
NAUTNautilus Biotechnology, Inc.COM9,111,151$19.3M0.6%00.0%UnchangedHistory
MDGLMadrigal Pharmaceuticals, Inc.COM331,023$21.5M0.6%−36,478−9.9%ReducedHistory
RVNCRevance Therapeutics, Inc.COM808,671$21.8M0.6%+236,157+41.2%AddedHistory
TARSTarsus Pharmaceuticals, Inc.COM1,296,416$22.2M0.6%00.0%UnchangedHistory
CMAXCareMax, Inc.COM CL A3,394,939$24.1M0.7%+394,939+13.2%AddedHistory
IMTXImmatics N.V.SHS2,500,000$25.0M0.7%00.0%UnchangedHistory
APLSApellis Pharmaceuticals, Inc.COM366,400$25.0M0.7%+45,100+14.0%AddedHistory
VRDNViridian Therapeutics, Inc.COM1,220,575$25.0M0.7%+248,743+25.6%AddedHistory
ADMAAdma Biologics, Inc.COM10,933,387$26.6M0.8%−587,715−5.1%ReducedHistory
ZYMEZymeworks Inc.COM4,400,099$27.1M0.8%+267,565+6.5%AddedHistory
EWEdwards Lifesciences CorpStock330,000$27.3M0.8%+330,000NewHistory
SRPTSarepta Therapeutics, Inc.COM253,000$28.0M0.8%+253,000NewHistory
BMRNBiomarin Pharmaceutical IncCOM336,481$28.5M0.8%+156,481+86.9%AddedHistory
ESTAEstablishment Labs Holdings Inc.COM578,253$31.6M0.9%+172,494+42.5%AddedHistory
NUVLNuvalent, Inc.COM1,655,007$32.2M0.9%00.0%UnchangedHistory
TMCITreace Medical Concepts, Inc.COM1,601,979$35.4M1.0%+660,787+70.2%AddedHistory
VBIVVBI Vaccines Inc/BCCOM NEW52,335,002$37.2M1.1%00.0%UnchangedHistory
RAPTRAPT Therapeutics, Inc.COM1,713,134$41.2M1.2%−200,657−10.5%ReducedHistory
SGENSeagen Inc.COM316,544$43.3M1.3%+92,544+41.3%AddedHistory
RLAYRelay Therapeutics, Inc.COM1,943,097$43.5M1.3%00.0%UnchangedHistory
VERUVeru Inc.COM3,893,000$44.8M1.3%+393,000+11.2%AddedHistory
ALBOAlbireo Pharma, Inc.COM2,360,139$45.7M1.3%00.0%UnchangedHistory
LYRALyra Therapeutics, Inc.COM9,146,730$45.8M1.3%00.0%UnchangedHistory
Travere Therapeutics, Inc.89422GAA5NOTE 2.250% 3/0–$46.0M1.3%–––
ACLXArcellx, Inc.COMMON STOCK2,465,405$46.3M1.3%+1,323,415+115.9%AddedHistory
COGTCogent Biosciences, Inc.COM3,207,441$47.9M1.4%+118,469+3.8%AddedHistory
VRNAVerona Pharma plcSPONSORED ADS5,047,264$51.6M1.5%+2,132,118+73.1%AddedHistory
INBXInhibrx Biosciences, Inc.COM2,887,860$51.8M1.5%+973,268+50.8%AddedHistory
MGTXMeiraGTx Holdings plcCOM6,963,277$58.6M1.7%00.0%UnchangedHistory

Options (1)

Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.

Option positions of Perceptive Advisors LLC in Q3 2022
SecurityClassPutsCalls
TCDATricida, Inc.COM$5.24M–

Sold out since Q2 2022 (9)

Positions held at the end of Q2 2022 that are gone from this filing.

Positions of Perceptive Advisors LLC sold out since Q2 2022
SecurityClassShares in Q2 2022Value in Q2 2022% of portfolio in Q2 2022History
LLYEli Lilly & CoStock100,000$32.4M1.0%History
ALNYAlnylam Pharmaceuticals, Inc.COM172,991$25.2M0.8%History
DAWNDay One Biopharmaceuticals, Inc.Stock556,047$9.95M0.3%History
PRVAPrivia Health Group, Inc.COM273,423$7.96M0.3%History
NUVBNuvation Bio Inc.COM CL A1,769,701$5.73M0.2%History
MGNXMacrogenics IncCOM1,227,202$3.62M0.1%History
FUSNFusion Pharmaceuticals Inc.COM1,052,445$2.62M0.1%History
RACEFerrari N.V.COM6,200$1.14M<0.1%History
ZYZymergen Inc.COM883,332$1.09M<0.1%History